{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New Paltz",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88843",
      "recalling_firm": "Ultra Seal Corporation",
      "address_1": "521 Main St",
      "address_2": "N/A",
      "postal_code": "12561-1609",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0072-2022",
      "product_description": "ZEE+ painaid ESF Extra-Strength Formula (Acetaminophen 250 mg, Aspirin 250 mg (NSAID), Caffeine 65 mg) tablets, 2 Tablets per/package, Packaged in a) 50-count packages/carton, b) 125-count packages/carton, PA-ESF 1414Z, Dist. by: Zee Medical Distributors, LLC Mason, OH 45040 (Shipping Label)",
      "product_quantity": "1,968,150 tablets",
      "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.",
      "recall_initiation_date": "20211013",
      "center_classification_date": "20211026",
      "termination_date": "20220328",
      "report_date": "20211103",
      "code_info": "Lot #: AK-9547, exp. date 22- Apr; AK-9941, exp. date 22-Dec"
    }
  ]
}